Bretylate,
Bretylium Tosilate,
Bretylium Tosylate,
Bretylol,
Ornid,
Bretylium tosylate,
61-75-6,
Bretylol,
Bretylium tosilate,
Bretylate,
Ornid,
Bretylan,
Darenthin,
Darentin,
N-(2-bromobenzyl)-N,N-dimethylethanaminium 4-methylbenzenesulfonate,
Bretylium p-toluenesulfonate,
Bretylii tosilas,
ASL-603,
Tosilato de bretilio,
Bretylium (tosylate),
Tosilate de bretylium,
Bretilio tosilato [DCIT],
(o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate,
NSC 62164,
UNII-78ZP3YR353,
Bretylii tosilas [INN-Latin],
Bretylium Tosylate In Dextrose 5%,
Tosilate de bretylium [INN-French],
Tosilato de bretilio [INN-Spanish],
EINECS 200-516-8,
Bretylium Tosylate In Plastic Container,
2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-methylbenzenesulfonate,
Dimethylethyl-o-bromobenzylammonium-p-toluenesulphonate,
N-Ethyl-N-o-bromobenzyl-N,N-dimethylammonium tosylate,
MLS000028635,
CHEBI:3173,
ASL 603,
78ZP3YR353,
Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1),
CAS-61-75-6,
NCGC00016119-02,
AK-81946,
SMR000058647,
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER,
Bretylium tosilate (INN),
Bretylium tosilate [INN],
Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid,
AMMONIUM, (o-BROMOBENZYL)ETHYLDIMETHYL-, p-TOLUENESULFONATE,
Bretilio tosilato,
NSC62164,
SR-01000000254,
Bretylium tosylate (USP),
C11H17BrN.C7H7O3S,
Bretylium tosylate [USAN:BAN],
Bretylium tosylate [USAN:USP],
bretyliume tosylate,
Bretylol (TN),
Opera_ID_1513,
Lopac-B-8406,
DSSTox_CID_2685,
AC1L1LT0,
AC1Q26DL,
C18H24BrNO3S,
DSSTox_RID_76691,
DSSTox_GSID_22685,
SCHEMBL40898,
CHEMBL1095292,
DTXSID1022685,
CTK8B6650,
HMS1570N06,
HMS2097N06,
HMS2235I21,
HMS3714N06,
Tox21_110308,
ANW-53884,
HY-12961A,
MFCD00038731,
NSC-62164,
RW1157,
AKOS015842525,
API0001757,
CCG-204319,
CS-5728,
KS-0000012R,
NCGC00016119-01,
NCGC00016119-03,
NCGC00016119-04,
NCGC00024457-02,
AN-23717,
LS-16927,
WLN: ER B1K2&1&1 &OSWR D1,
Bretylium tosylate, >99% (TLC), powder,
AB2000538,
AX8118682,
TC-061525,
(2-bromobenzyl)ethyldimethylammonium tosylate,
4CH-007114,
EU-0100224,
FT-0080900,
FT-0603258,
ST24031295,
V2113,
B 8406,
D00645,
SR-01000000254-2,
SR-01000000254-5,
(2-bromobenzyl)ethyldimethylammonium toluene-4-sulfonate,
N-Ethyl-N-(o-bromobenzyl)-N,N-dimethylammonium Tosylate,
(2-bromophenyl)methyl-ethyl-dimethylazanium; 4-methylbenzenesulfonate,
(2-bromophenyl)methyl-ethyl-dimethylazanium;4-methylbenzenesulfonate,
N-(2-Bromobenzyl)-N,N-dimethylethanaminium4-methylbenzenesulfonate,
(2-bromophenyl)methyl-ethyl-dimethyl-ammonium; 4-methylbenzenesulfonate,
2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-methyl-benzenesulfontate,
Bretylium tosylate, United States Pharmacopeia (USP) Reference Standard,
N-[(2-bromophenyl)methyl]-N,N-dimethylethanaminium 4-methylbenzenesulfonate,
Benzenemethanaminium,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1),
bretyliumtosilat-,
Bretylium tolsylate,
Ammonium, p-toluenesulfonate,
CID6100,
AR-1I0747,
C11-H17-Br-N.C7-H7-O3-S,
D001950,
(o-bromobenzyl)ethyldimethyl-ammoniup-toluenesulfonate,
(o-bromobenzyl)ethyldimethylammonium p-toluenesul-fon-ate,
N-(2-Bromobenzyl)-N,N-dimethylethaminium 4-methylbenzenesulfote,
2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-methylbenzenesulfonate (1:1),
6297-62-7,